InnoCare Pharma Deal History & Licensing Activity
InnoCare Pharma is a biotech headquartered in US. Over the past three years, InnoCare Pharma has been involved in 2 licensing and acquisition transactions, with a primary focus on Other (2 deals). The company currently has 2 active clinical trials, primarily in Other.
Deals (12mo)
2
Active Trials
2
Top Modality
Other
Focus Area
Other
InnoCare Pharma Recent Deal Activity
Licensing, acquisition, and partnership transactions involving InnoCare Pharma in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Multi-target research collaboration (up to 5 targets) | Eli Lilly and Company | Other | Discovery | collaboration | Sep 24, 2026 |
InnoCare Pharma Pipeline Focus
Therapeutic areas and modalities where InnoCare Pharma is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
InnoCare Pharma Strategic Signals
Key indicators of InnoCare Pharma's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
InnoCare Pharma Clinical Pipeline
InnoCare Pharma has 2 active clinical trials across 2 development phases.
1
Phase 1
1
Phase 3
See How Your Asset Matches InnoCare Pharma's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Other assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Neurology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for neurology
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 700+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About InnoCare Pharma Licensing & Deal Activity
InnoCare Pharma is a biotech company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, InnoCare Pharma ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for InnoCare Pharma include Other (2 deals and trials), Neurology (1 deal and trial), and Hematological Malignancies (1 deal and trial). In terms of modality, InnoCare Pharma has shown particular interest in other, small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for InnoCare Pharma and 700+ other biopharma companies. Use our Solidus to benchmark your asset against InnoCare Pharma's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.